Baltimore sues J&J unit over ‘sham’ litigation to extend Xtandi patent STAT
The city claims Janssen undertook a “ruse” when seeking a patent for its Xtandi drug by failing to disclose certain information to U.S. patent authorities.
Baltimore sues J&J unit over ‘sham’ litigation to extend Xtandi patent STAT
The city claims Janssen undertook a “ruse” when seeking a patent for its Xtandi drug by failing to disclose certain information to U.S. patent authorities.